Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCEPsychopharmacology — drug interactions and QTc

Psych CASC / OSCE · Psychopharmacology — drug interactions and QTc

Explaining QTc risk and medicine changes after a near-syncope (CASC)

CASC-style communication station: explain drug-induced QTc risk in plain language, negotiate safer medicine changes, electrolyte correction, and follow-up without abandoning mental health care.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 55-year-old woman on citalopram 40 mg and quetiapine, recently started on clarithromycin, had near-syncope. ECG QTc 505 ms, K+ 3.1. She is frightened you will 'stop all her mental health tablets' and leave her depressed and sleepless.

Station instructions (candidate)

You have 7 minutes. Explain why her heart-rhythm risk rose (medicines + low potassium + antibiotic), what QTc means in plain language, and the plan: correct potassium, review/stop temporary culprits (clarithromycin), adjust psychotropics thoughtfully (citalopram dose/agent and quetiapine risk context), monitor ECG, and protect her mental health with a clear follow-up. Do not promise zero risk. Do not strip all psychotropics without a plan. Do not use unexplained jargon.[1][2][3]

Marking domains

Empathy and agenda; accurate plain-language QTc/TdP risk; multi-hit model (drugs + electrolytes + antibiotic); collaborative deprescribing/switching; safety-netting for syncope; shared decision and written plan; avoids both panic and minimisation.[1][4][5]

Model communication map

  1. Open: thank her for coming; name the shared goals — stay safe from collapse and keep mood/sleep protected.[5]
  2. Plain QTc: "The ECG shows the recovery time of each heartbeat is longer than we like; when it gets too long, rare dangerous rhythms can cause faints."[1][4]
  3. Why now: combination of mental health medicines that can stretch that interval, a heart-sensitive antibiotic, and low potassium — risk adds up rather than one villain alone.[1][2][4]
  4. Immediate plan: replace potassium (and magnesium if low); stop or switch clarithromycin with the medical team; repeat ECG; monitoring if still very prolonged.[2]
  5. Psychotropic plan: review citalopram dose/choice (higher-dose citalopram has more QTc signal in research) and quetiapine need/dose; change one step at a time with a covering plan for sleep and mood.[3][1][5]
  6. Safety-net: if she faints, nearly faints, or has pounding irregular heartbeats — emergency care; list of medicines to show any doctor.[2]
  7. Close: questions, written summary, GP/pharmacy communication, follow-up date.[5]

Common fails

  • "All psychiatric drugs are dangerous — stop everything today" without a mental health plan.[5]
  • Ignoring the antibiotic and low potassium and blaming only "the antidepressant."[2][4]
  • Over-reassuring "QTc never matters with modern meds."[1]
  • Using only acronyms (TdP, IKr, Bazett) without checking understanding.[1]

References

  1. [1]Beach SR, Celano CM, Noseworthy PA, et al. QTc prolongation, torsades de pointes, and psychotropic medications Psychosomatics, 2013.PMID 23295003
  2. [2]Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation Circulation, 2010.PMID 20142454
  3. [3]Castro VM, Clements CC, Murphy SN, et al. QT interval and antidepressant use: a cross sectional study of electronic health records BMJ, 2013.PMID 23360890
  4. [4]Roden DM Drug-induced prolongation of the QT interval N Engl J Med, 2004.PMID 14999113
  5. [5]Funk MC, Beach SR, Bostwick JR, et al. QTc Prolongation and Psychotropic Medications Am J Psychiatry, 2020.PMID 32114782